Stay updated on EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Sign up to get notified when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.

Latest updates to the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this is a minor metadata update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe Publications section text was updated to clarify that publications are automatically filled from PubMed. The revision version was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check32 days agoChange DetectedThe government funding notice at the top of the page was removed. Study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check46 days agoChange DetectedA publication citation (Wang JS et al., Invest New Drugs. 2025) was added to the Publications section and the same citation was removed. This is a minor bibliographic update and does not affect core content or how users interact with the page.SummaryDifference0.5%

- Check75 days agoChange DetectedUpdates include a new status notice about funding and operations plus a version bump to v3.2.0, replacing the old v3.0.2.SummaryDifference3%

- Check90 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the previous “Back to Top” line and added a new revision tag, indicating a minor update focused on versioning rather than substantive content.SummaryDifference0.2%

Stay in the know with updates to EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.